Pfizer takes stake in French Lyme disease jab partner Valneva
Pfizer has acquired an 8.1% stake in French vaccines developer Valneva at a cost of €90.5 million (around $95 million) and rejigged the terms of […]
Pfizer has acquired an 8.1% stake in French vaccines developer Valneva at a cost of €90.5 million (around $95 million) and rejigged the terms of […]
For those who crave pizza-related news, Little Caesars is now the official pizza sponsor for the NFL, replacing Pizza Hut, which has held the position for […]
Roughly 14 percent of the global population has been infected with Lyme disease, and its prevalence is only growing, according to a study published Monday. […]
There’s only one vaccine candidate for tick-borne infection Lyme disease in clinical development – Valneva and Pfizer’s VLA15 – and it has just moved another […]
Prospects for Valneva’s COVID-19 vaccine are up in the air, but another candidate partnered with Pfizer looks increasingly like it could fill the void of […]
Date: July 12, 2021 Issue #: 1628 Summary: The Centers for Disease Control and Prevention (CDC) and the Environmental Protection Agency (EPA) recommend using insect […]
Valneva has said it plans to accelerate research into its Lyme disease vaccine candidate VLA15, bringing forward a trial including children into the first quarter […]
Copyright © 2024 | WordPress Theme by MH Themes